Submit your email address to sign up for the Visionary,
or monthly newletter.

X

Search the Radiation Oncology Institute

X

Submit your email address to sign up for the Visionary,
or monthly newletter.

X

Search the Radiation Oncology Institute

X
Close Index

The Visionary (Winter 2020, Vol. 10, No. 4)

Growing Startup Has Roots in ROI Grant
Todd McNutt, PhD, provides an update on is his project, “Predictive modeling for toxicities in head and neck cancer from Oncospace.” 
An Extraordinary Year for ROI Research
Our growing portfolio of practical and relevant research addresses the timely issue of health equity, and the biomarkers RFP shattered a record for applications.
Generating ROI
Ted Lawrence, MD, PhD, FASTRO, helped found the ROI and reflects upon the investment and its returns as he prepares to step down from the Board of Trustees. 
Gifts That Pay You Income
Learn more about charitable gift annuities, a new planned giving option for the ROI. 
#GivingTuesday Launches Year-End Giving
Join your generous colleagues, who provided a strong start to the giving season, in supporting critical research for radiation oncology in 2020.  
Brian Marples, PhD
ASTRO Science Council Vice-Chair Brian Marples, PhD, joined the ROI President’s Circle with a monthly contribution because of recent research successes.
Your Gift at Work
ROI researchers Adam Wolfe, MD, PhD, and Terence Williams, MD, PhD, aim to personalize treatments for pancreatic cancer.
 
Issue Index

An Extraordinary Year for ROI Research

From the very beginning, the ROI has filled a special niche for radiation oncology by supporting research that provides practical solutions to some of the field’s most pressing challenges. When the ROI released the Improving Diversity and Inclusion in Radiation Oncology request for proposals in the fall of 2019, we recognized an urgent need to address disparities in patient care and to develop a more diverse workforce. The four grants awarded in 2020 took on additional importance and significance with the profound events of this year that brought attention to the inequity and injustice present throughout society.

The ROI is proud to support the four teams who are conducting research that aims to improve cancer care for people of color and those who identify as LGBTQ+. These grants allow for innovative collaborations across disciplines that are necessary to solve the complex problems that they seek to address, and the ROI is uniquely positioned to provide such support. We are hopeful that the outcomes from these research projects will make a difference for medically vulnerable populations and are committed to ensuring that future awards foster equity, inclusivity and diversity both in terms of the patients served and the teams conducting the research.

We were thrilled to see the overwhelming response to the ROI’s recent request for proposals (RFP) on Biomarkers for Radiation Oncology. Many talented researchers saw great potential to investigate new ways to use biomarkers to improve outcomes for patients receiving radiotherapy and submitted 72 letters of intent, shattering the ROI’s previous record of 50. This year’s extraordinarily popular RFP resulted from the successful launch of the ROI’s new Corporate Research Forum who recommended biomarkers as one of three timely and important topics to the ROI’s Research Committee who developed the full RFP. The application review process has begun, and the ROI is looking forward to announcing the awards that will support research on biomarkers to enhance patient selection, develop personalized treatment regimens, quantify outcomes and manage toxicity in Spring 2021.

The ROI is your research foundation, and we are grateful for your continued support as we work toward a better future for all patients and providers in the radiation oncology community.